DE60326859D1 - Arzneimittelverabreichung - Google Patents

Arzneimittelverabreichung

Info

Publication number
DE60326859D1
DE60326859D1 DE60326859T DE60326859T DE60326859D1 DE 60326859 D1 DE60326859 D1 DE 60326859D1 DE 60326859 T DE60326859 T DE 60326859T DE 60326859 T DE60326859 T DE 60326859T DE 60326859 D1 DE60326859 D1 DE 60326859D1
Authority
DE
Germany
Prior art keywords
drugs
drugs administration
relates
delivery
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60326859T
Other languages
English (en)
Inventor
Ijeoma Uchegbu
Andreas Schatzlein
Woei Ping Cheng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
School of Pharmacy University of London
Original Assignee
School of Pharmacy University of London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by School of Pharmacy University of London filed Critical School of Pharmacy University of London
Application granted granted Critical
Publication of DE60326859D1 publication Critical patent/DE60326859D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0206—Polyalkylene(poly)amines
    • C08G73/0213—Preparatory process
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0206—Polyalkylene(poly)amines
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0206—Polyalkylene(poly)amines
    • C08G73/0213—Preparatory process
    • C08G73/0226—Quaternisation of polyalkylene(poly)amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60326859T 2002-09-20 2003-09-22 Arzneimittelverabreichung Expired - Lifetime DE60326859D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0221942.6A GB0221942D0 (en) 2002-09-20 2002-09-20 Drug delivery
PCT/GB2003/004036 WO2004026941A1 (en) 2002-09-20 2003-09-22 Drug delivery

Publications (1)

Publication Number Publication Date
DE60326859D1 true DE60326859D1 (de) 2009-05-07

Family

ID=9944516

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60326859T Expired - Lifetime DE60326859D1 (de) 2002-09-20 2003-09-22 Arzneimittelverabreichung

Country Status (11)

Country Link
US (1) US20060148982A1 (de)
EP (1) EP1543063B1 (de)
JP (1) JP2006500437A (de)
AT (1) ATE426635T1 (de)
AU (1) AU2003267581A1 (de)
CA (1) CA2499681A1 (de)
DE (1) DE60326859D1 (de)
DK (1) DK1543063T3 (de)
GB (1) GB0221942D0 (de)
SI (1) SI1543063T1 (de)
WO (1) WO2004026941A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0422877D0 (en) * 2004-10-14 2004-11-17 Univ Glasgow Bioactive polymers
US8057821B2 (en) * 2004-11-03 2011-11-15 Egen, Inc. Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
CA2637560C (en) 2006-01-19 2013-11-26 Allexcel, Inc. Solubilization and targeted delivery of drugs with self-assembling amphiphilic polymers
CA2636739A1 (en) * 2006-01-27 2007-08-02 Ciba Holding Inc. Polymeric anti-microbial agents
US8399007B2 (en) * 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
US20100004124A1 (en) * 2006-12-05 2010-01-07 David Taft Systems and methods for delivery of materials for agriculture and aquaculture
US20090246155A1 (en) * 2006-12-05 2009-10-01 Landec Corporation Compositions and methods for personal care
US20090263346A1 (en) * 2006-12-05 2009-10-22 David Taft Systems and methods for delivery of drugs
EP2500015A1 (de) * 2006-12-05 2012-09-19 Landec Corporation Verabreichung von Arzneimitteln
BRPI0720573A2 (pt) * 2006-12-22 2014-02-04 Basf Se Uso de polialquilenoiminas c2-4 hidrofobicamente modificadas
JP5296787B2 (ja) * 2007-07-19 2013-09-25 オールエクセル，インコーポレイティド 抗癌剤としての自己集合性の両親媒性ポリマー
US8114883B2 (en) * 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
FR2928373B1 (fr) 2008-03-05 2010-12-31 Centre Nat Rech Scient Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
GB0903559D0 (en) 2009-03-02 2009-04-08 Univ London Pharmacy Oral delivery of hydrophilic drugs to the brain
JP5814913B2 (ja) 2009-04-28 2015-11-17 サーモディクス，インコーポレイテッド 生物活性薬剤の送達装置および送達方法
GB0915449D0 (en) 2009-09-04 2009-10-07 Univ Robert Gordon Composition
US9714481B2 (en) 2010-04-28 2017-07-25 The University Of Georgia Research Foundation, Inc Photochemical cross-linkable polymers, methods of making photochemical cross-linkable polymers, methods of using photochemical cross-linkable polymers, and methods of making articles containing photochemical cross-linkable polymers
US8721936B2 (en) 2011-04-21 2014-05-13 University Of Georgia Research Foundation, Inc. Devices and methods for forming non-spherical particles
US10213529B2 (en) 2011-05-20 2019-02-26 Surmodics, Inc. Delivery of coated hydrophobic active agent particles
US9861727B2 (en) 2011-05-20 2018-01-09 Surmodics, Inc. Delivery of hydrophobic active agent particles
CA2841000C (en) 2011-07-15 2020-02-25 University Of Georgia Research Foundation, Inc. Permanent attachment of agents to surfaces containing c-h functionality
US9439421B2 (en) 2011-08-04 2016-09-13 University Of Georgia Research Foundation, Inc. Permanent attachment of ammonium and guanidine-based antimicrobials to surfaces containing -OH functionality
WO2013056007A2 (en) 2011-10-14 2013-04-18 University Of Georgia Research Foundation, Inc. Photochemical cross-linkable polymers, methods of making photochemical cross-linkable plolymers, methods of using photochemical cross-linkable poloymers, and methods of making articles containing photochemical cross-linkable polymers
JP6438406B2 (ja) * 2012-11-05 2018-12-12 サーモディクス，インコーポレイテッド 疎水性生理活性物質を送達するための組成物および方法
US11246963B2 (en) 2012-11-05 2022-02-15 Surmodics, Inc. Compositions and methods for delivery of hydrophobic active agents
US10898446B2 (en) 2016-12-20 2021-01-26 Surmodics, Inc. Delivery of hydrophobic active agents from hydrophilic polyether block amide copolymer surfaces
JP2021065776A (ja) * 2021-02-04 2021-04-30 株式会社三洋物産 遊技機

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5879022A (ja) * 1981-11-04 1983-05-12 Bitamin Kenkyusho:Kk 第四級窒素原子を含有する新規な金属架橋高分子化合物、その製法及び該高分子化合物を有効成分とする高脂血症治療剤
US5338532A (en) * 1986-08-18 1994-08-16 The Dow Chemical Company Starburst conjugates
US5681543A (en) * 1988-02-29 1997-10-28 Shering Aktiengesellschaft Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI
JPH01236240A (ja) * 1989-01-14 1989-09-21 Miyoshi Oil & Fat Co Ltd 新規な高分子化合物
DE3901527A1 (de) * 1989-01-20 1990-07-26 Hoechst Ag Alkylierte polyethyleniminderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel sowie pharmazeutische praeparate
JP3406970B2 (ja) * 1993-12-27 2003-05-19 ミヨシ油脂株式会社 両性界面活性剤
JP3526661B2 (ja) * 1995-06-23 2004-05-17 ミヨシ油脂株式会社 抗菌剤、抗菌性樹脂及び抗菌性塗料
WO1997048673A1 (en) * 1996-06-19 1997-12-24 The Procter & Gamble Company Process for removing malodors from modified polyamines
WO1999043752A1 (fr) * 1998-02-27 1999-09-02 Dnavec Research Inc. Compositions pour transporter des substances chargees negativement
JP3523821B2 (ja) * 2000-02-09 2004-04-26 ナノキャリア株式会社 薬物が封入されたポリマーミセルの製造方法および該ポリマーミセル組成物
US6696038B1 (en) * 2000-09-14 2004-02-24 Expression Genetics, Inc. Cationic lipopolymer as biocompatible gene delivery agent
AU2001289943A1 (en) * 2000-10-09 2002-04-22 Bayer Aktiengesellschaft Complexes for transferring nucleic acids into cells
DE10065710A1 (de) * 2000-12-29 2002-07-04 Bayer Ag Arzneimittel enthaltend ein Polyamin als Wirksubstanz
GB0221941D0 (en) * 2002-09-20 2002-10-30 Univ Strathclyde Polysoaps

Also Published As

Publication number Publication date
AU2003267581A8 (en) 2004-04-08
EP1543063B1 (de) 2009-03-25
GB0221942D0 (en) 2002-10-30
AU2003267581A1 (en) 2004-04-08
ATE426635T1 (de) 2009-04-15
JP2006500437A (ja) 2006-01-05
SI1543063T1 (sl) 2009-08-31
CA2499681A1 (en) 2004-04-01
EP1543063A1 (de) 2005-06-22
DK1543063T3 (da) 2009-05-18
US20060148982A1 (en) 2006-07-06
WO2004026941A1 (en) 2004-04-01

Similar Documents

Publication Publication Date Title
DE60326859D1 (de) Arzneimittelverabreichung
CY1111458T1 (el) Μορφες δοσολογιας γενικως γραμμικης, αναβραζουσας, απο του στοματος φεντανυλης και μεθοδοι χορηγησης
CY1118179T1 (el) Φαρμακευτικη συνθεση
BRPI0514293A (pt) sais de dicetopiperazina, sais de dicetomorfolina ou sais de dicetodioxano para administração de droga
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
EA200702522A1 (ru) Система доставки лекарств в полость рта и способы ее применения
IL174154A (en) History of GLP-1 New Pharmaceutical Preparations Containing Them and Using It to Make Medicines
TW200605870A (en) Topical methadone compositions and methods for using the same
BRPI0507680A (pt) partìculas de fosfato de cálcio terapêuticas e métodos de fabricação e uso das mesmas
ATE465255T1 (de) Verabreichung von sirnas
EA200600877A1 (ru) Наночастицы для доставки лекарств
NO20063429L (no) Brusende oral opiat doseringsform
BRPI0608297A2 (pt) composições de lipossomos
CY1105211T1 (el) Φαρμακευτικοι συνδυασμοι που πepιλαμβανουν εναν ανταγωνιστη του υποδοχεα p2τ και μελαγατρανη
UA85574C2 (uk) Ендопаразитоцидний засіб для місцевого застосування
DE60327693D1 (de) Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff
NO20062605L (no) Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper
UY27929A1 (es) Composiciones farmaceuticas de farmacos semiordenados y polimeros
DE602005011818D1 (de) Aminotropanderivate, deren herstellung und deren therapeutische verwendung
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
DE60205905D1 (de) Pharmazeutische zusammensetzung zur orale verabreichung mit verbesserter bioverfügbarkeit
ATE454136T1 (de) Therapeutische zusammensetzungen zur pulmonalen verabreichung
ATE434431T1 (de) Pharmazeutische formulierungen mit kurzketten- sphingolipiden und ihre verwendung
EA200970353A1 (ru) Комбинированное лекарственное средство

Legal Events

Date Code Title Description
8364 No opposition during term of opposition